Clifford M. Samuel ‘88
Clifford M. Samuel ‘88 is vice president of International Access Operations at Gilead Sciences Inc. in Foster City, California. Under Clifford’s leadership, the program is pioneering the development of innovative manufacturing, distribution, and support infrastructure models to accelerate treatment access across the developing world.
Clifford joined Gilead in March of 1996 as a therapeutic specialist. In 2001, he was promoted to National Accounts Manager (NAM), where he developed and exponentially expanded the NAM team into three distinct divisions in order to keep pace with Gilead’s growth within the antiviral marketplace. Clifford was later promoted to senior director of national accounts. In 2004, he was appointed as Gilead’s senior director of commercial operations, where he focused on expanding critical business functions in areas such as analytics and forecasting, business operations and contract compliance, market research, training and development. In January of 2010, Clifford was promoted to vice president of International Access Operations.
Prior to joining Gilead Sciences, Clifford was a sales representative at ICI Pharmaceuticals, focusing on the cardiovascular market. Following his tenure at ICI, he joined Glaxo Pharmaceuticals in 1992, where he represented various products in the antibiotic, CNS, oncology and respiratory markets. In 1995, Clifford was promoted to Glaxo’s HIV/Oncology Specialty Division, where he launched 3TC and represented AZT.
Clifford earned his degree in mechanical engineering from New Jersey Institute of Technology. He serves on the Community Advisory Board for the UCSF AIDS Health Project (AHP) and the Albert Dorman Honors College Board of Visitors.